Deciphering the source and consequences of Nur77 expression during E. coli rUTI in mice
Deciphering the source and consequences of Nur77 expression during E. coli rUTI in mice
批准号:
10431538
负责人:
Nicole Marie Gilbert
金额:
$11.81万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-04-01 至 2024-03-31
关键词:
AffectAgeAntibiotic ResistanceApoptosisApplications GrantsBacteriaBacterial VaginosisBiologicalBiological AssayBladderBladder TissueBladder UrotheliumBreedingBypassC57BL/6 MouseCatheterizationCellsClinicalCoitusDataDiseaseDot ImmunoblottingEpidemiologyEpithelialEpithelial CellsEscherichia coliExhibitsExposure toFemaleFlow CytometryFutureGardnerella vaginalisGenetic TranscriptionGenitourinary systemHistologyHumanImmediate-Early GenesImmuneImmune responseImmunofluorescence MicroscopyInfectionInflammationInflammatoryInflammatory ResponseInterferon Type IIInterleukin-12Knock-outLactobacillusLinkMediatingModelingMolecularMusNeedlesNuclear Orphan ReceptorNuclear ReceptorsPathogenesisPathway interactionsPhosphate BufferPopulationPredispositionProductionPublishingRANTESRecurrenceReporterResearch PersonnelRiskRisk FactorsRoleSalineSeedsSourceSpecific qualifier valueStainsT-LymphocyteTestingThe Jackson LaboratoryTissuesUPK3 geneUrinary tractUrinary tract infectionUrineUrothelial CellUrotheliumVaginaWild Type MouseWomanbasecell typecostcytokinedysbiosisexperienceexperimental studyinsightintravesicalmalemicrobialmouse modelrecurrent infectionrenal epitheliumresponsetranscriptome sequencing
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT
Recurrent urinary tract infection (rUTI) is a costly clinical problem that affects millions of women worldwide and
contributes to the global rise in antibiotic resistance. Multiple lines of evidence indicate that bacteria in the vagina
can affect susceptibility to UTI. For example, women with the vaginal dysbiosis called bacterial vaginosis (BV)
are at increased risk of UTI. Several vaginal bacteria—including the BV-associated species Gardnerella vaginalis
(G.v.)—have been isolated from urine collected directly from the bladder by needle aspiration or transurethral
catheterization. Although culture conditions are not often poised to detect it, the presence of G.v. in urine is also
epidemiologically linked with rUTI. We have developed new mouse models to define the impact of vaginal
bacteria on UTI from a new perspective—testing the idea that transient bladder exposures to vaginal bacteria
such as G.v. influence the pathogenesis of Escherichia coli (E.c.), the leading cause of UTI. We previously
demonstrated that G.v. triggers apoptosis and exfoliation of the bladder epithelium in mice. When mice harbored
latent intracellular bladder reservoirs of E.c. from a prior experimental infection, G.v. triggered emergence of E.c.
and rUTI at a rate 4-fold higher than mice exposed to vehicle alone. These data indicate that bladder exposures
to G.v. could represent a trigger of rUTI in women.
To understand at the cellular and molecular level how G.v. triggers exfoliation and rUTI, we have examined the
transcriptional response to G.v. in the bladder using bulk RNA sequencing. This analysis revealed that G.v.
induced the expression of the orphan nuclear receptor Nur77 (also called Nr4a1). Nur77 is well-recognized for
its role in apoptosis and in inflammatory responses in diseases in other tissues, but its role in the urinary tract is
largely unstudied. Our preliminary data using Nur77-/- mice indicate that Nur77 is required for G.v. to trigger E.c.
rUTI in our mouse model. In this focused R03, we seek to answer two fundamental questions regarding the
contribution of Nur77 to G.v.-induced E.c. rUTI: Which cell types in the bladder express Nur77 following G.v.
exposure? (Aim 1), and Which host responses to G.v. exposure—exfoliation or inflammatory cytokine
production—are mediated by Nur77? (Aim 2). Our proposed experiments build upon our preliminary data and
leverage available Nur77 knockout and reporter mice and our experience in detailing bladder responses to
microbial exposures. Successful completion of these studies will provide important mechanistic insights into how
G.v. triggers E.c. rUTI and will generate key data on which to build a future R01 proposal.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A co-infection model for papillomavirus associated infections and cancers
-
批准号:10667710
-
项目类别:
-
资助金额:$24.88万
-
财政年份:2023
-
负责人:Nicole Marie Gilbert
-
依托单位:
Deciphering the source and consequences of Nur77 expression during E. coli rUTI in mice
-
批准号:10593109
-
项目类别:
-
资助金额:$11.7万
-
财政年份:2022
-
负责人:Nicole Marie Gilbert
-
依托单位:
Role of Gardnerella vaginalis in the Urinary Tract
-
批准号:9912142
-
项目类别:
-
资助金额:$11.17万
-
财政年份:2017
-
负责人:Nicole Marie Gilbert
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: